Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The ischaemic lactate-ammonia test.

C Livingstone1, P F Chinnery, D M Turnbull

  • 1Clinical Biochemistry Department, Royal Surrey County Hospital, Guildford, UK. clivingstone@Royalsurrey.nhs.uk

Annals of Clinical Biochemistry
|July 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depression, anxiety and PTSD symptoms before and during the COVID-19 pandemic in the UK.

Psychological medicine·2022
Same author

Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress.

Neuropathology and applied neurobiology·2020
Same author

Moving on from responsible gambling: a new discourse is needed to prevent and minimise harm from gambling.

Public health·2020
Same author

Inheritance of mitochondrial DNA in humans: implications for rare and common diseases.

Journal of internal medicine·2020
Same author

Systematic review of cognitive deficits in adult mitochondrial disease.

European journal of neurology·2019
Same author

Design and baseline characteristics of the Biomarkers Of Risk In Colorectal Cancer (BORICC) Follow-Up study: A 12+ years follow-up.

Nutrition and health·2019
Same journal

Limitations of spectrophotometry in the analysis of cerebrospinal fluid bilirubin.

Annals of clinical biochemistry·2026
Same journal

Commentary on the impact of lithium heparin vacutainer tubes on daily cerebrospinal fluid analysis.

Annals of clinical biochemistry·2026
Same journal

Routine laboratory triage for NT-proBNP elevation may reflect cardiorenal frailty as much as heart failure specificity.

Annals of clinical biochemistry·2026
Same journal

From interpretable NT-proBNP prediction to equitable laboratory stewardship.

Annals of clinical biochemistry·2026
Same journal

Serum Sclerostin Levels in Children with Osteogenesis Imperfecta.

Annals of clinical biochemistry·2026
Same journal

Population-Specific HOMA-IR Reference Ranges in Iraq: Defining Insulin Sensitivity in a Middle Eastern Cohort.

Annals of clinical biochemistry·2026
See all related articles

The ischaemic lactate-ammonia test screens for metabolic muscle disorders by measuring forearm exercise response. This review clarifies its specific clinical applications for diagnosing muscle pain and fatigue.

Area of Science:

  • Clinical biochemistry
  • Exercise physiology
  • Neuromuscular disorders

Background:

  • The ischaemic lactate-ammonia test is a common diagnostic tool for unexplained muscle pain and fatigue.
  • It assesses metabolic responses to forearm exercise under restricted blood flow.
  • The test aims to identify potential carbohydrate metabolism disorders.

Purpose of the Study:

  • To review the established clinical utility of the ischaemic lactate-ammonia test.
  • To audit the application of this test within specific clinical departments.
  • To delineate the precise situations where the test provides valuable diagnostic information for metabolic myopathies.

Main Methods:

  • Review of existing literature on the ischaemic lactate-ammonia test methodology and applications.

Related Experiment Videos

  • Audit of patient records to assess the test's utilization and diagnostic yield.
  • Analysis of plasma lactate and ammonia levels post-forearm exercise under ischaemic conditions.

    • Main Results:

    • The test is primarily used for screening patients with muscle complaints suggestive of metabolic dysfunction.
    • Variations in test protocols exist, impacting diagnostic accuracy.
    • An audit was conducted to evaluate the test's real-world application and effectiveness.

    Conclusions:

    • The ischaemic lactate-ammonia test is a specialized screening tool, not a universal diagnostic for all muscle diseases.
    • Its effectiveness is dependent on specific clinical indications and optimized methodology.
    • Further investigation is warranted for patients identified by the test as potentially having metabolic muscle disorders.